Weight LossNCT04377906
The Effect High Protein-Fiber Diet With Exercise on Acylated Ghrelin and Leptin in Obese Adolescents
A study testing Modification Lifesyle in people with Weight Loss and Adolescent Obesity, run by Universitas Diponegoro at 1 site in Indonesia.
Trial summary
Obesity has been reported to impair regulation of appetite and lead uncontrollably hunger and satiety response. Ghrelin is orexigenic hormone from the stomach meanwhile, leptin is anorexigenic from adipose. Interestingly, obesity is associated with acylated ghrelin and leptin resistance. Read more about this study
- Who is it for?
- Ages 19 to 20 years
- Conditions the study is for
- Weight Loss, Adolescent Obesity
- What is being tested?
- Modification Lifesyle
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 56 participants
- Where
- 1 siteIndonesia
- Study dates
- 1 Jun 2018to 30 Oct 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 20 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- body mass index > 25 kg/m2,
- waist circumference >80 cm for female and >90 cm for male
Who cannot join
- taking dietary supplements or medication
- smokers
- have pregnancy
- lose body weight > 10% before treatment
- have chronic disease history
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Department of Nutrition Science, Medical Faculty, Universitas Diponegoro Semarang, Indonesia
Obesity has been reported to impair regulation of appetite and lead uncontrollably hunger and satiety response. Ghrelin is orexigenic hormone from the stomach meanwhile, leptin is anorexigenic from adipose. Interestingly, obesity is associated with acylated ghrelin and leptin resistance. Study about the impact of high protein and fiber with combined exercise (HPFE) to suppress hunger among young obese still unclear. The hypothesis was that high protein-fiber would result in decreased in acylated ghrelin and leptin in HPFE group. Thus, the investigator examined the effect of an 8 weeks HPFE on acylated ghrelin and leptin. Subjects were randomized into four groups: High Protein-Fiber (HPF; n=15). High Protein-Fiber and exercise (HPFE; n=15), Exercise (E; n=15) and control (C; n=15). The diet prescribed 1200 kcal/day, based on basic energy requirement minus 300kcal, consisted high protein (25%) and fiber (30g/day). The exercise is combination aerobic and resistance training, with target 75% heart rate maximum. Plasma acylated ghrelin and leptin were analyzed with enzyme immunoassay.
Read the detailed description
- Introduction Obesity pandemic occurred in both developed and developing countries. The prevalence of young obesity is rising among adolescents in developing countries as well, rising from 8.1% to 12.9% in 2013 for boys and from 8.4% to 13.4% in girls. The Indonesian Basic Health Research showed prevalence of young obesity in Indonesia increase from 18,8 menjadi 31% on 2007 till 2018. The prominent problem with young obesity is the accumulation of adipose cells in the abdominal which can interfere with appetite hormones. Ghrelin is the only known as orexigenic hormon which secreted from the stomach. The leptin is one of anorexigenic mainly released by the adipose tissue. The orexigenic hormone acylated ghrelin and the anorexigenic hormones leptin are an important players in regulating appetite, food intake, energy balance, and adipogenesis. Regarding body weight regulation, key element are the control of energy intake which is regulated at the simplest level by sensation of hunger. Body weight is controlled by a complex system, including both peripheral and central factors. Two of the hormones that appear to play a crucial role in the regulation of food intake and body weight are leptin and ghrelin. Interestingly, obesity is associated with acylated ghrelin and leptin resistance. Hyperleptinemia is blunted response in satiety. Postprandial acylated ghrelin levels in obesity abdominal subjects do not fall, so hunger still appears. In obese subjects experience leptin resistance because the leptin receptor is disrupted so that there is a failure of sending leptin signals to the hypothalamus. Many study especially about acylated ghrelin still controversial. Studi Andarini showed plasma AG concentration is higher before and after eating at all time points, regardless of food type, in obese individuals, as compared with normal weight individuals. Consistant with the Ozkan et al reveal the AG increase following obesity status. Different types of protein can result in different levels of satiety. Metabolites, including certain amino acids, contribute to the food intake is arginine. The ability of specific L-amino acids, including L-arginine (L-Arg), to stimulate anorectic agent (GLP-1 and PYY) release has been studied previously in vitro. The study Alamshah et al showed L-Arg reduced food intake and stimulated gut hormone release in rodents. The role fiber affect the release satiety and gastric emptying rate. Managing weight loss with modification lifestyle in young obesity actually requires paying special attention to high compliance and less hunger more satiety. The study aimed to examine the effect of giving a high protein diet rich arginine and fiber diet with exercise among adolescent obesity.
- Methods and Matherials 2.1 Participants The program was conducted from Juli to Oktober 2018. Subject were recruited through nutrition screening and campaign mass media. For sample size, the investigator calculated previous studies regarding AG with following setting: power was set at 80%, p value at 0.5 and standardized difference was 21.2, resulting in a sampel size of 12 subjects, including 20% for drop out. Inclusion criteria are body mass index > 25 kg/m2, waist circumference >80 cm for female and >90 cm for male. The investigator exclude who were taking dietary supplements or medication, smokers, have pregnancy, lose body weight > 10% before treatment and have chronic disease history. The participants consisted of 60 adolescents obesity who were selected from outpatient of Universitas Diponegoro, Semarang, Indonesia. Subjects were randomized into four groups : High Protein-Fiber (HPF; n=15). High Protein-Fiber and exercise (HPFE; n=15), Exercise (E; n=15) and control (C; n=15). All participants has signed informed consent and the study was approved by Kariadi Hospital-Diponegoro University with provision Declaration of Helsinki (Number 427/EC/FK-UNDIP/VII/2018)
2.1 Study design and randomization. The study design was randomized clinical trial (four-arm). The random assignment was generated by a computerized program. The duration of intervention is 8 weeks. It was not possible to blind the dietitians who advised on dietary prescribe.
3.1 Diet protocol The subject were randomly into four of different intervention. The HPFE prescribed balanced diet (55%carbohydrate, 25% protein, and 20% fat). Based on the Academy Dietetics of Association recommends using the Miflin-St Jeor equation for estimating RMR in obese individuals. Subject have body weight means 75 kg, so the total energy was calculated 1500 kcal,then minus 300kcal. The distribution energy of breakfast (30%), lunch (40%) and dinner (30%) and extra 500ml plan water before meal. The investigator choose the protein sources rich arginine like all type fish, tempeh, nuts/peas. The investigator serve the diet menu everyday in our laboratory. The diet was prescribed with the use of standardazied household measure to quatify the food portion in each meal. The subjects were monitored the diet everyday with logbook. The control group give nutrition education once a week in nutrition laboratory. The nutritional data was calculated by software (Nutrisurvey).
4.1 Exercise protocol
One session of training program included the following program component :
- 5 min warm-up; 2) 25 min aerobic training; 3) 10 min resistance training, 4) 5 min cool-down. The resistance training was performed without weight training machine (chalestenic). The movement includes plank, mountain climber, pilates leg pulls, right side plank, left side plank, flutter kick, toe touch crunches, crunch, knee tuck crunches and russian twist. The muscle strength level by 40 repetition maximum (RM). Rest between the sets of the resistance training was set 20reps. The aerobic training was performed koreographic for at least 25 min and the intensity was 75% heart rate maximum. The frequency of training was five times a week (on alternate day) under professional trainer. Heart rate during training was monitored using HR monitor (H10, POLLAR, Kemple, Finland)
5.1 Body composition Body weight, and percent body fat mass, were analyzed by a bioelectric impedance analyzer (TANITA DC-360) with light clothes and no shoes. Height was measured by stadiometer (SECA 207). BMI was calculated as body weight in kilograms divided by height in meters squared (kg/m2). Waist Circumference (WC) was measured with a inelastic measuring tape around the mid-section between the margin of the last rib and the iliac crest.
6.1 Hormone Analysis Venous blood samples were obtain after 10h fasting. Blood samples for insulin and leptin were stored in plain tubes, and acylated ghrelin were stored in tubes with EDTA. For active ghrelin, immediately after collection, 40 mL p-hydroxymercuribenzoic acid was added to each blood sample. The samples were centrifuged at 3500X at 4C for 10 min. For acyl ghrelin, after centrifugation, the plasma was pipetted in 1.5-mL microtubes, and 100 mL hydrochloric acid (1N) was added for each 1 mL plasma. For all blood sample, the respective supernatant fluids were pipetted and frozen at 80°C for a later analysis by an enzyme-linked immunoassay (Elabscience E-EL-H2002 for AG, E-EL-H0113 for leptin). Blood samples for trigliserida and HDL were stored in tubes with non EDTA, and analyzed with clinical chemistry automatic analyzer (Indiko thermoscientific).
7.1 Statistical Analysis Data were analyzed IBM SPSS. Variable not normally distributed were nonparametric test. Wann whitney U test was used to test for difference all parameter at baseline. We compared change in variable (baseline-week8) in each sub group using pair t=test or wilcoxon signed rank test to determine the impact of differential change. To test for change in parameters between four group used kruskal wallis.
- Conditions
- Weight Loss, Adolescent Obesity
- Being tested
- Modification Lifesyle
- Keywords
- high protein-fiber, acylated ghrelin, leptin
- Medical subject headings
- Weight Loss, Pediatric Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modification LifesyleBehavioural
high protein-fiber and exercise
| Study group | Role | What they receive |
|---|---|---|
| High Protein-Fiber and Exercise | Experimental | give 1200 Kcal with 25% protein from fish and tempeh and 30g fiber from vegetable and fruit, 3 times/day and exercise : aerobic and resistance training for 5x/week, 45 minute each sesion Receives: Behavioral: Modification Lifesyle |
| High Protein-Fiber | Experimental | give 1200 Kcal with 25% protein from fish and tempeh and 30g fiber from vegetable and fruit, 3 times/day Receives: Behavioral: Modification Lifesyle |
| Exercise | Experimental | aerobic and resistance training for 5x/week, 45 minute each sesion Receives: Behavioral: Modification Lifesyle |
| control | No intervention | regular diet |
What is being measured
The primary outcome is the main question the study is designed to answer.
change acylated ghrelin
Change from Baseline acyl ghrelin at 8 weeks taken in the lab from venous blood specimen after10h fasting using ELISA method
Measured: 8 weeks
change leptin
Change from Baseline leptin at 8 weeks taken in the lab from venous blood specimen after10h fasting using ELISA method
Measured: 8 weeks
change body weight
change from baseline body weight at 8 weeks measured using bioelectrical impedance analysis (BIA) with light clothes and no shoes
Measured: 8 weeks
Secondary outcomes (2)
change triglyceride
change from baseline triglyceride at 8 weeks taken in the lab from venous blood specimen after10h fasting
Measured: 8 weeks
change high density lipoprotein
change from baseline high density lipoprotein at 8 weeks taken in the lab from venous blood specimen after10h fasting
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2020
- Study start1 Jun 2018
- Primary completion1 Sep 2018
- Study completion30 Oct 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weight LossStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- four arm parallel group with 56 young obesity: 1. high protein-fiber diet and exercise 2. high protein-fiber diet 3. exercise 4. control
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitas Diponegoro
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Etika Ratna Noer, Universitas Diponegoro
- Investigators
- Etika Noer, Principal investigator, Diponegoro University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04377906
- Sponsor's protocol ID
- ERN
- Status last verified
- Jun 2020
- First submitted
- 21 Apr 2020
- Last updated
- 16 Jun 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: the result of this study is available to cite everyone
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Department of Nutrition Science, Medical Faculty, Universitas Diponegoro Semarang, Indonesia
- ClinicalTrials.gov ID
- NCT04377906
- Acronym / sponsor ID
- ERN
- Conditions
- Weight Loss, Adolescent Obesity
- Keywords
- high protein-fiber, acylated ghrelin, leptin
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Universitas DiponegoroUniversity, hospital or other
- Study start
- 1 Jun 2018 (actual)
- Primary completion
- 1 Sep 2018 (actual)
- Study completion
- 30 Oct 2018 (actual)
- First posted
- 7 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Obesity has been reported to impair regulation of appetite and lead uncontrollably hunger and satiety response. Ghrelin is orexigenic hormone from the stomach meanwhile, leptin is anorexigenic from adipose. Interestingly, obesity is associated with acylated ghrelin and leptin resistance. Study about the impact of high protein and fiber with combined exercise (HPFE) to suppress hunger among young obese still unclear. The hypothesis was that high protein-fiber would result in decreased in acylated ghrelin and leptin in HPFE group. Thus, the investigator examined the effect of an 8 weeks HPFE on acylated ghrelin and leptin. Subjects were randomized into four groups: High Protein-Fiber (HPF; n=15). High Protein-Fiber and exercise (HPFE; n=15), Exercise (E; n=15) and control (C; n=15). The diet prescribed 1200 kcal/day, based on basic energy requirement minus 300kcal, consisted high protein (25%) and fiber (30g/day). The exercise is combination aerobic and resistance training, with target 75% heart rate maximum. Plasma acylated ghrelin and leptin were analyzed with enzyme immunoassay.
Detailed description
- Introduction Obesity pandemic occurred in both developed and developing countries. The prevalence of young obesity is rising among adolescents in developing countries as well, rising from 8.1% to 12.9% in 2013 for boys and from 8.4% to 13.4% in girls. The Indonesian Basic Health Research showed prevalence of young obesity in Indonesia increase from 18,8 menjadi 31% on 2007 till 2018. The prominent problem with young obesity is the accumulation of adipose cells in the abdominal which can interfere with appetite hormones. Ghrelin is the only known as orexigenic hormon which secreted from the stomach. The leptin is one of anorexigenic mainly released by the adipose tissue. The orexigenic hormone acylated ghrelin and the anorexigenic hormones leptin are an important players in regulating appetite, food intake, energy balance, and adipogenesis. Regarding body weight regulation, key element are the control of energy intake which is regulated at the simplest level by sensation of hunger. Body weight is controlled by a complex system, including both peripheral and central factors. Two of the hormones that appear to play a crucial role in the regulation of food intake and body weight are leptin and ghrelin. Interestingly, obesity is associated with acylated ghrelin and leptin resistance. Hyperleptinemia is blunted response in satiety. Postprandial acylated ghrelin levels in obesity abdominal subjects do not fall, so hunger still appears. In obese subjects experience leptin resistance because the leptin receptor is disrupted so that there is a failure of sending leptin signals to the hypothalamus. Many study especially about acylated ghrelin still controversial. Studi Andarini showed plasma AG concentration is higher before and after eating at all time points, regardless of food type, in obese individuals, as compared with normal weight individuals. Consistant with the Ozkan et al reveal the AG increase following obesity status. Different types of protein can result in different levels of satiety. Metabolites, including certain amino acids, contribute to the food intake is arginine. The ability of specific L-amino acids, including L-arginine (L-Arg), to stimulate anorectic agent (GLP-1 and PYY) release has been studied previously in vitro. The study Alamshah et al showed L-Arg reduced food intake and stimulated gut hormone release in rodents. The role fiber affect the release satiety and gastric emptying rate. Managing weight loss with modification lifestyle in young obesity actually requires paying special attention to high compliance and less hunger more satiety. The study aimed to examine the effect of giving a high protein diet rich arginine and fiber diet with exercise among adolescent obesity.
- Methods and Matherials 2.1 Participants The program was conducted from Juli to Oktober 2018. Subject were recruited through nutrition screening and campaign mass media. For sample size, the investigator calculated previous studies regarding AG with following setting: power was set at 80%, p value at 0.5 and standardized difference was 21.2, resulting in a sampel size of 12 subjects, including 20% for drop out. Inclusion criteria are body mass index > 25 kg/m2, waist circumference >80 cm for female and >90 cm for male. The investigator exclude who were taking dietary supplements or medication, smokers, have pregnancy, lose body weight > 10% before treatment and have chronic disease history. The participants consisted of 60 adolescents obesity who were selected from outpatient of Universitas Diponegoro, Semarang, Indonesia. Subjects were randomized into four groups : High Protein-Fiber (HPF; n=15). High Protein-Fiber and exercise (HPFE; n=15), Exercise (E; n=15) and control (C; n=15). All participants has signed informed consent and the study was approved by Kariadi Hospital-Diponegoro University with provision Declaration of Helsinki (Number 427/EC/FK-UNDIP/VII/2018)
2.1 Study design and randomization. The study design was randomized clinical trial (four-arm). The random assignment was generated by a computerized program. The duration of intervention is 8 weeks. It was not possible to blind the dietitians who advised on dietary prescribe.
3.1 Diet protocol The subject were randomly into four of different intervention. The HPFE prescribed balanced diet (55%carbohydrate, 25% protein, and 20% fat). Based on the Academy Dietetics of Association recommends using the Miflin-St Jeor equation for estimating RMR in obese individuals. Subject have body weight means 75 kg, so the total energy was calculated 1500 kcal,then minus 300kcal. The distribution energy of breakfast (30%), lunch (40%) and dinner (30%) and extra 500ml plan water before meal. The investigator choose the protein sources rich arginine like all type fish, tempeh, nuts/peas. The investigator serve the diet menu everyday in our laboratory. The diet was prescribed with the use of standardazied household measure to quatify the food portion in each meal. The subjects were monitored the diet everyday with logbook. The control group give nutrition education once a week in nutrition laboratory. The nutritional data was calculated by software (Nutrisurvey).
4.1 Exercise protocol
One session of training program included the following program component :
- 5 min warm-up; 2) 25 min aerobic training; 3) 10 min resistance training, 4) 5 min cool-down. The resistance training was performed without weight training machine (chalestenic). The movement includes plank, mountain climber, pilates leg pulls, right side plank, left side plank, flutter kick, toe touch crunches, crunch, knee tuck crunches and russian twist. The muscle strength level by 40 repetition maximum (RM). Rest between the sets of the resistance training was set 20reps. The aerobic training was performed koreographic for at least 25 min and the intensity was 75% heart rate maximum. The frequency of training was five times a week (on alternate day) under professional trainer. Heart rate during training was monitored using HR monitor (H10, POLLAR, Kemple, Finland)
5.1 Body composition Body weight, and percent body fat mass, were analyzed by a bioelectric impedance analyzer (TANITA DC-360) with light clothes and no shoes. Height was measured by stadiometer (SECA 207). BMI was calculated as body weight in kilograms divided by height in meters squared (kg/m2). Waist Circumference (WC) was measured with a inelastic measuring tape around the mid-section between the margin of the last rib and the iliac crest.
6.1 Hormone Analysis Venous blood samples were obtain after 10h fasting. Blood samples for insulin and leptin were stored in plain tubes, and acylated ghrelin were stored in tubes with EDTA. For active ghrelin, immediately after collection, 40 mL p-hydroxymercuribenzoic acid was added to each blood sample. The samples were centrifuged at 3500X at 4C for 10 min. For acyl ghrelin, after centrifugation, the plasma was pipetted in 1.5-mL microtubes, and 100 mL hydrochloric acid (1N) was added for each 1 mL plasma. For all blood sample, the respective supernatant fluids were pipetted and frozen at 80°C for a later analysis by an enzyme-linked immunoassay (Elabscience E-EL-H2002 for AG, E-EL-H0113 for leptin). Blood samples for trigliserida and HDL were stored in tubes with non EDTA, and analyzed with clinical chemistry automatic analyzer (Indiko thermoscientific).
7.1 Statistical Analysis Data were analyzed IBM SPSS. Variable not normally distributed were nonparametric test. Wann whitney U test was used to test for difference all parameter at baseline. We compared change in variable (baseline-week8) in each sub group using pair t=test or wilcoxon signed rank test to determine the impact of differential change. To test for change in parameters between four group used kruskal wallis.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 4
- Model description
- four arm parallel group with 56 young obesity: 1. high protein-fiber diet and exercise 2. high protein-fiber diet 3. exercise 4. control
| Arm | Type | Receives |
|---|---|---|
| High Protein-Fiber and Exercise | Experimental | Behavioral: Modification Lifesylegive 1200 Kcal with 25% protein from fish and tempeh and 30g fiber from vegetable and fruit, 3 times/day and exercise : aerobic and resistance training for 5x/week, 45 minute each sesion |
| High Protein-Fiber | Experimental | Behavioral: Modification Lifesylegive 1200 Kcal with 25% protein from fish and tempeh and 30g fiber from vegetable and fruit, 3 times/day |
| Exercise | Experimental | Behavioral: Modification Lifesyleaerobic and resistance training for 5x/week, 45 minute each sesion |
| control | No intervention | –regular diet |
Who may qualify
- Ages
- 19 to 20 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- body mass index > 25 kg/m2,
- waist circumference >80 cm for female and >90 cm for male
Key exclusion criteria (5 listed)
- taking dietary supplements or medication
- smokers
- have pregnancy
- lose body weight > 10% before treatment
- have chronic disease history
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modification Lifesylehigh protein-fiber and exercise | Behavioural | Exercise, High Protein-Fiber, High Protein-Fiber and Exercise |
Primary outcome
change acylated ghrelin
Time frame: 8 weeks
Change from Baseline acyl ghrelin at 8 weeks taken in the lab from venous blood specimen after10h fasting using ELISA method
change leptin
Time frame: 8 weeks
Change from Baseline leptin at 8 weeks taken in the lab from venous blood specimen after10h fasting using ELISA method
change body weight
Time frame: 8 weeks
change from baseline body weight at 8 weeks measured using bioelectrical impedance analysis (BIA) with light clothes and no shoes
2 secondary outcomes
change triglyceride
Time frame: 8 weeks
change high density lipoprotein
Time frame: 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2020.
- Individual participant dataSharing planned: Yes. the result of this study is available to cite everyone
Related trials for Weight Loss
Recruiting
Preserving Muscle Mass During Incretin-Induced Weight Loss
Obesity (BMI > 35)
Active, not recruiting
Healthy Living After Knee Replacement
Arthroplasty, Overweight and Obesity
Not yet recruitingPhase 4
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Obesity & Overweight, Cardiometabolic Health Indicators
Not yet recruitingPhase 2
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
Obesity, Overweight
Active, not recruiting
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
Severe Acute Malnutrition, Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Etika Noer principal investigator
Diponegoro University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Modification Lifesyle in people with Weight Loss and Adolescent Obesity, run by Universitas Diponegoro at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change acylated ghrelin (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2020.